Prebiotic formulations and methods of use
AssigneeRitter Pharmaceuticals, Inc.
InventorsAndrew J. RITTER, Dennis SAVAIANO, David BARNES, Todd KLAENHAMMER
Life of this patent
Estimating the term…
Abstract
The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.
Claims32
A method of treating lactose intolerance in a subject experiencing one or more symptoms of lactose intolerance comprising administering a pharmaceutical composition to said subject, wherein at least about 95% of said pharmaceutical composition is GOS, wherein said subject is administered between 1.5 and 15 g of said pharmaceutical composition per day.
A pharmaceutically acceptable oral dosage form of GOS comprising one or more dosing units, each of said dosing units comprising 0.1 to 2 g of a GOS composition wherein said GOS composition is a liquid encapsulated in a gelatin capsule.
A method of treating lactose intolerance in a subject experiencing one or more symptoms of lactose intolerance comprising:
- a. administering a hydrogen breath test (HBT) to said subject;
- b. diagnosing said subject as having or not having lactose intolerance based upon a HBT result;
- and,
- c. administering a prebiotic composition to said subject diagnosed as having lactose intolerance based upon said HBT results, wherein said prebiotic composition comprises GOS.
Dependencies are inferred from the claim text.